Behavioral interventions that are led by parents and learned at home can improve autism symptoms in toddlers.

The newest entrant in the list of unusual autism therapies is a chemical mixture extracted from broccoli sprouts. The extract seems to improve social skills in young men with autism, a small pilot study has found.

The preliminary success of a therapy designed to help infants with symptoms of autism raises broader questions about the potential promise and many challenges of early intervention.

The University of California has launched an ambitious 18-month project to connect autism researchers across its ten campuses.

Reports of a century-old drug that reverses autism-like symptoms in mice raise key questions about the complexity of translating promising research into real treatments.

A Duke University team has won $15 million to explore stem cells from cord blood as a treatment for autism. But experts caution that the trial is premature.

A single dose of a drug used to treat African sleeping sickness temporarily improves symptoms of autism in a mouse model, according to a study published last week in Translational Psychiatry.

Watch the complete replay of Jeremy Veenstra-VanderWeele’s webinar on conceptual pathways for developing effective autism drugs.

A new policy that aims to eliminate gender bias in animal and cell-based biomedical research is outlined in the 15 May Nature.
 

Following disappointing results from two clinical trials, the Swiss pharmaceutical company Novartis announced on 24 April that it will stop development of a drug candidate for fragile X syndrome.